Albuterol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Albuterol Sulfate.
| Product ID | 70771-1512_8c3c17d7-5fef-4953-830e-ca73cddf842a |
| NDC | 70771-1512 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Albuterol |
| Generic Name | Albuterol |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-23 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA208884 |
| Labeler Name | Cadila Healthcare Limited |
| Substance Name | ALBUTEROL SULFATE |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-0255 | Albuterol | albuterol sulfate |
| 0378-0572 | Albuterol | albuterol sulfate |
| 21695-198 | Albuterol | Albuterol |
| 51079-657 | Albuterol | albuterol |
| 51079-658 | Albuterol | albuterol |
| 55289-045 | Albuterol | albuterol sulfate |
| 59651-333 | Albuterol | Albuterol |
| 59651-334 | Albuterol | Albuterol |
| 63629-2611 | Albuterol | albuterol |
| 64980-442 | Albuterol | albuterol |
| 64980-443 | Albuterol | albuterol |
| 69238-1344 | Albuterol | Albuterol |
| 69238-1345 | Albuterol | Albuterol |
| 69339-126 | Albuterol | albuterol sulfate |
| 69339-127 | Albuterol | albuterol sulfate |
| 69543-290 | Albuterol | Albuterol |
| 69543-291 | Albuterol | Albuterol |
| 70710-1061 | Albuterol | Albuterol |
| 70710-1062 | Albuterol | Albuterol |
| 70954-078 | Albuterol | Albuterol |
| 70954-079 | Albuterol | Albuterol |
| 70771-1511 | Albuterol | Albuterol |
| 70771-1512 | Albuterol | Albuterol |
| 75834-273 | Albuterol | Albuterol |
| 75834-274 | Albuterol | Albuterol |
| 66689-100 | Albuterol Sulfate | Albuterol |